A detailed history of Td Asset Management Inc transactions in Nuvalent, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 39,866 shares of NUVL stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,866
Holding current value
$3.02 Million
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$67.44 - $112.17 $2.69 Million - $4.47 Million
39,866 New
39,866 $4.08 Million
Q1 2024

May 08, 2024

SELL
$72.35 - $88.99 $3.01 Million - $3.7 Million
-41,600 Reduced 76.36%
12,878 $967,000
Q4 2023

Feb 12, 2024

BUY
$42.42 - $80.28 $379,828 - $718,827
8,954 Added 19.67%
54,478 $4.01 Million
Q3 2023

Oct 27, 2023

BUY
$39.12 - $49.85 $1.3 Million - $1.66 Million
33,262 Added 271.26%
45,524 $2.09 Million
Q4 2022

Feb 06, 2023

BUY
$18.46 - $36.37 $226,356 - $445,968
12,262 New
12,262 $365,000

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.26B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.